NK cell recognition : Adaptability to host factors in normal and diabetic mice

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Unknown venue

• Publication date

  2005-04-01

• Fields of study

  Biology, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of FASL-induced apoptosis in the elimination of tumor cells by NK cells.

  2005cited by this paper
• The NOD mouse: a model of immune dysregulation.

  2005cited by this paper
• NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors.

  2005cited by this paper
• A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules.

  2005cited by this paper
• HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection

  2004cited by this paper
• The role of CD94/NKG2 in innate and adaptive immunity

  2004cited by this paper
• Mapping of the BALB/c Ly49 cluster defines a minimal natural killer cell receptor gene repertoire.

  2004cited by this paper
• Regulation of Autoimmune Diabetes by Complete Freund’s Adjuvant Is Mediated by NK Cells

  2004cited by this paper
• Cis association of Ly49A with MHC class I restricts natural killer cell inhibition

  2004cited by this paper
• Association of killer cell immunoglobulin-like receptors with scleroderma.

  2004cited by this paper
• Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming

  2004cited by this paper
• Homeostatic expansion of T cells during immune insufficiency generates autoimmunity.

  2004cited by this paper
• LFA-1 Contributes an Early Signal for NK Cell Cytotoxicity

  2004cited by this paper
• Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcɛRIγ and CD3ζ

  2004cited by this paper
• The Abundant NK Cells in Human Secondary Lymphoid Tissues Require Activation to Express Killer Cell Ig-Like Receptors and Become Cytolytic1

  2004cited by this paper
• Cutting Edge: Heterozygote Advantage in Autoimmune Disease: Hierarchy of Protection/Susceptibility Conferred by HLA and Killer Ig-Like Receptor Combinations in Psoriatic Arthritis1

  2004cited by this paper
• Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity.

  2004cited by this paper
• Characterization and distribution of lymphocyte subpopulations in multiple sclerosis plaques versus autoimmune demyelinating lesions

  2004cited by this paper
• Essential Roles of CD8+CD122+ Regulatory T Cells in the Maintenance of T Cell Homeostasis

  2004cited by this paper
• Bone Marrow Allograft Rejection Mediated by a Novel Murine NK Receptor, NKG2I

  2004cited by this paper
• Driven to autoimmunity: the nod mouse.

  2004cited by this paper
• NK Cells Stimulate Proliferation of T and NK Cells through 2B4/CD48 Interactions1

  2004cited by this paper
• 2B4 Acts As a Non–Major Histocompatibility Complex Binding Inhibitory Receptor on Mouse Natural Killer Cells

  2004cited by this paper
• The role of T cells in beta cell damage in NOD mice and humans.

  2004cited by this paper
• Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors.

  2004cited by this paper
• Role of a NK receptor, KLRE-1, in bone marrow allograft rejection: analysis with KLRE-1-deficient mice.

  2004cited by this paper
• KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects.

  2003cited by this paper
• Control of autoimmunity by naturally arising regulatory CD4+ T cells.

  2003cited by this paper
• Regulation of perforin‐independent NK cell‐mediated cytotoxicity

  2003cited by this paper
• Identification of a new murine lectin-like gene in close proximity to CD94

  2003cited by this paper
• The Lectin-like Receptor KLRE1 Inhibits Natural Killer Cell Cytotoxicity

  2003cited by this paper
• Models for Natural Killer Cell Repertoire Formation

  2003cited by this paper
• Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease

  2003cited by this paper
• Impairment of NK cell function by NKG2D modulation in NOD mice.

  2003cited by this paper
• Generation of the natural killer cell repertoire: The sequential vs. the two-step selection model

  2003cited by this paper
• Cutting Edge: Molecular Cloning of a Killer Cell Ig-Like Receptor in the Mouse and Rat 1

  2003cited by this paper
• Circulating natural killer cells in psoriasis

  2003cited by this paper
• Identification of the mouse killer immunoglobulin-like receptor-like (Kirl) gene family mapping to Chromosome X

  2003cited by this paper
• Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors

  2003cited by this paper
• Sequence analysis of the ly49 cluster in C57BL/6 mice: a rapidly evolving multigene family in the immune system.

  2002cited by this paper
• Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants

  2002cited by this paper
• The role of the NKG2D immunoreceptor in immune cell activation and natural killing.

  2002cited by this paper
• Natural killer cell activation in mice and men: different triggers for similar weapons?

  2002cited by this paper
• The unconventional lifestyle of NKT cells

  2002cited by this paper
• Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors

  2002cited by this paper
• A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors

  2002cited by this paper
• Cutting Edge: Susceptibility to Psoriatic Arthritis: Influence of Activating Killer Ig-Like Receptor Genes in the Absence of Specific HLA-C Alleles1

  2002cited by this paper
• Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases

  2002cited by this paper
• The Role of NK Cells in Autoimmune Disease

  2002cited by this paper
• A view to a kill: signals triggering cytotoxicity.

  2002cited by this paper
• Target cell defense prevents the development of diabetes after viral infection

  2002cited by this paper
• KIR: diverse, rapidly evolving receptors of innate and adaptive immunity.

  2002cited by this paper
• A BAC contig map of the Ly49 gene cluster in 129 mice reveals extensive differences in gene content relative to C57BL/6 mice.

  2002cited by this paper
• Understanding autoimmune diabetes: insights from mouse models.

  2002cited by this paper
• Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells

  2002cited by this paper
• Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D

  2002cited by this paper
• Role of chemokines in the biology of natural killer cells

  2002cited by this paper
• The Natural Killer Cell – Friend or Foe in Autoimmune Disease?

  2002cited by this paper
• Recognition of a virus-encoded ligand by a natural killer cell activation receptor

  2002cited by this paper
• Contact-dependent Stimulation and Inhibition of Dendritic Cells by Natural Killer Cells

  2002cited by this paper
• Syk Regulation of Phosphoinositide 3-Kinase-Dependent NK Cell Function1

  2002cited by this paper
• Reciprocal Activating Interaction between Natural Killer Cells and Dendritic Cells

  2002cited by this paper
• NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation

  2002cited by this paper
• Total β-Human Chorionic Gonadotropin Measured in Urine by an Automated Method

  2002cited by this paper
• The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice

  2001cited by this paper
• Type 1 diabetes: new perspectives on disease pathogenesis and treatment.

  2001cited by this paper
• Specific and nonspecific NK cell activation during virus infection

  2001cited by this paper
• Cutting Edge: Regulation of CD8+ T Cell Proliferation by 2B4/CD48 Interactions1

  2001cited by this paper
• Vav‐1 regulates NK T cell development and NK cell cytotoxicity

  2001cited by this paper
• Damage control, rather than unresponsiveness, effected by protective DX5+ T cells in autoimmune diabetes

  2001cited by this paper
• Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu.

  2001cited by this paper
• Cd1-Restricted Nk T Cells Protect Nonobese Diabetic Mice from Developing Diabetes

  2001cited by this paper
• 2B4 (CD244)-Mediated Activation of Cytotoxicity and IFN-γ Release in Human NK Cells Involves Distinct Pathways1

  2001cited by this paper
• A Central Role for Death Receptor-Mediated Apoptosis in the Rejection of Tumors by NK Cells1

  2001cited by this paper
• Ly-49W, an Activating Receptor of Nonobese Diabetic Mice With Close Homology to the Inhibitory Receptor Ly-49G, Recognizes H-2Dk and H-2Dd1

  2001cited by this paper
• Protection Against Diabetes and Improved NK/NKT Cell Performance in NOD.NK1.1 Mice Congenic at the NK Complex1

  2001cited by this paper
• MHC‐dependent shaping of the inhibitory Ly49 receptor repertoire on NK cells: evidence for a regulated sequential model

  2001cited by this paper
• Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice.

  2001cited by this paper
• CD28 co-stimulation restores T cell responsiveness in NOD mice by overcoming deficiencies in Rac-1/p38 mitogen-activated protein kinase signaling and IL-2 and IL-4 gene transcription.

  2001cited by this paper
• Regulation of the natural killer cell receptor repertoire.

  2001cited by this paper
• Specificity and function of activating Ly‐49 receptors

  2001cited by this paper
• Cumulative Inhibition of NK Cells and T Cells Resulting from Engagement of Multiple Inhibitory Ly49 Receptors1

  2001cited by this paper
• NK T Cell-Induced Protection Against Diabetes in Vα14-Jα281 Transgenic Nonobese Diabetic Mice Is Associated with a Th2 Shift Circumscribed Regionally to the Islets and Functionally to Islet Autoantigen1

  2001cited by this paper
• Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models.

  2001cited by this paper
• Functional dichotomy in natural killer cell signaling: Vav1-dependent and -independent mechanisms.

  2001cited by this paper
• Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells

  2001cited by this paper
• IFN-γ/TNF-α Synergism as the Final Effector in Autoimmune Diabetes: A Key Role for STAT1/IFN Regulatory Factor-1 Pathway in Pancreatic β Cell Death1

  2001cited by this paper
• Major Histocompatibility Complex Class I–Recognizing Receptors Are Disease Risk Genes in Rheumatoid Arthritis

  2001cited by this paper
• MHC Class I-Ly49 Interactions Shape the Ly49 Repertoire on Murine NK Cells1

  2001cited by this paper
• ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.

  2001cited by this paper
• Clonal analysis of NK cell development from bone marrow progenitors in vitro: orderly acquisition of receptor gene expression

  2000cited by this paper
• Association of MHC Class I chain-related A (MIC-A) gene polymorphism with Type I diabetes

  2000cited by this paper
• Impaired Natural Killing of MHC Class I-Deficient Targets by NK Cells Expressing a Catalytically Inactive Form of SHP-11

  2000cited by this paper
• Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice.

  2000cited by this paper
• Activating Ly-49d and Inhibitory Ly-49a Natural Killer Cell Receptors Demonstrate Distinct Requirements for Interaction with H2-Dd

  2000cited by this paper
• Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice.

  2000cited by this paper
• Natural killer cells determine the outcome of B cell–mediated autoimmunity

  2000cited by this paper
• Suppression and acceleration of autoimmune diabetes by neutralization of endogenous interleukin-12 in NOD mice.

  2000cited by this paper
• Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages

  2000cited by this paper
• NK cell expression of the killer cell lectin‐like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules

  2000cited by this paper

• No citing papers are available for this paper.